A Phase II Study of Dasatinib Combined with Induction Chemotherapy in Previously Untreated de novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia to Assess Safety and Tolerability.
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2016
At a glance
- Drugs Dasatinib (Primary) ; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Methotrexate; Vincristine
- Indications Acute lymphoblastic leukaemia
- Focus Adverse reactions
- 08 Jun 2016 Status changed from recruiting to completed.
- 27 Feb 2009 New trial record